New research suggests terpenes and CBD twice as effective in treating Covid-19 inflammation than corticosteroid

In the fight against Covid-19, cytokine storms are one of the most deadly factors that doctors are battling. Read more…


Zelira partners with US research centre to treat symptoms of diabetes and heart disease

Zelira has partnered with US-based Cardiovascular Solutions of Central Mississippi to develop and commercialise CBD and hemp products to target symptoms associated with Peripheral Arterial Disease and Diabetic Neuropathies. Read more…


MGC Pharma trading halted ahead of news on ArtemiC safety and toxicity pre-clinical study results

MGC Pharmaceuticals is in a trading halt ahead of an announcement in relation to safety and toxicity pre-clinical study results on AtremiC. Read more…